Needham Maintains Buy Rating on Veradermics, Raises Target to $172
Needham raised its price target to $172 per share from $164 while maintaining its Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.